Clinical Trial

Investigating Neurocognitive Disorders Epidemiology

Study acronym: INDE
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective cohort study with the main purpose of predicting progression neurocognitive disorders in Thai population. The main predictor variables to be evaluated are plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for diagnosing disease pathologies, understand their correlation with clinical outcomes, and explore the socioeconomic impact of neurocognitive disorders. The study invites both participants for biospecimen collection, structured interviews, and cognitive examinations and schedules follow-up visits annually or biennially.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-16.
Trial Details
NCT Number NCT06375213
Lead Sponsor King Chulalongkorn Memorial Hospital
Collaborators: Health Systems Research Institute,Thailand
Conditions Dementia, Cognitive Decline, Alzheimer Disease
Enrollment 990 participants
Start Date 2023-08-24
Primary Completion 2035-08-24 (estimated)
Study Completion 2035-08-24 (estimated)
Updated on ClinicalTrials.gov 2024-04-22